Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Noboru Imai"'
Autor:
Noboru Imai, Yasuhiko Matsumori
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Migraine is a multifactorial brain disorder characterized by recurrent disabling headaches and their associated features. Several studies have suggested that these features are related to headache impact, pain intensity, and psychiatric cond
Externí odkaz:
https://doaj.org/article/ea9d52c011834158b2e4ba1694102be0
Autor:
Daisuke Danno, Noboru Imai, Shigekazu Kitamura, Kumiko Ishizaki, Shoji Kikui, Takao Takeshima
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Galcanezumab, a monoclonal antibody targeting the calcitonin gene-related peptide pathway (CGRP mAb), acts peripherally due to its large size. However, recent studies have suggested that CGRP mAbs may also have a central mode of action. This
Externí odkaz:
https://doaj.org/article/d0bb4eb582c842919f9ca919cd04f52e
Publikováno v:
NeuroSci, Vol 5, Iss 3, Pp 222-229 (2024)
Background: We have previously shown that static and dynamic resting-state functional connectivity differ between migraineurs with and without photophobia, phonophobia, or osmophobia. Furthermore, some patients with photophobia also experience phonop
Externí odkaz:
https://doaj.org/article/56e3fbd437f84867830eb19b8364a32a
Autor:
Tsubasa Takizawa, Keiko Ihara, Narumi Watanabe, Ryo Takemura, Nobuyuki Takahashi, Naoki Miyazaki, Mamoru Shibata, Keisuke Suzuki, Noboru Imai, Norihiro Suzuki, Koichi Hirata, Takao Takeshima, Jin Nakahara
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Anti-calcitonin gene-related peptide monoclonal antibodies (CGRPmAbs) have greatly changed migraine treatment options. In Japan, although CGRPmAb guidelines (≥ 4 monthly migraine days (MMDs) and ≥ 1 previous preventive failure
Externí odkaz:
https://doaj.org/article/01b79095541b444eb414caea23415c35
Autor:
Noboru Imai, Yuki Isogai, Yoshiyuki Shibasaki, Masami Nakai, Miki Ishida, Xiaoping Ning, Nobuyuki Koga
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 1981-1991 (2023)
Abstract Introduction Chronic migraine (CM) patients commonly take acute headache medications, often resulting in medication overuse (MO). This post hoc analysis evaluated the efficacy of fremanezumab in CM patients from Japan with and without MO, wh
Externí odkaz:
https://doaj.org/article/e5a4e02d0e424237a6a82a624ce122ed
Autor:
Mariko Okada, Masahito Katsuki, Tomokazu Shimazu, Takao Takeshima, Takashi Mitsufuji, Yasuo Ito, Katsumi Ohbayashi, Noboru Imai, Junichi Miyahara, Yasuhiko Matsumori, Yoshihiko Nakazato, Kazuki Fujita, Eri Hoshino, Toshimasa Yamamoto
Publikováno v:
Life, Vol 14, Iss 6, p 744 (2024)
The misdiagnosis of headache disorders is a serious issue, and AI-based headache model diagnoses with external validation are scarce. We previously developed an artificial intelligence (AI)-based headache diagnosis model using a database of 4000 pati
Externí odkaz:
https://doaj.org/article/37b3b9e5e73b4b59b14cfeb296b55864
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Migraine, a common primary headache disorder, is associated with various factors such as stress, hormones in women, fasting, weather, and sleep disturbance as well as odors. We aimed to categorize odors associated with migraine and explore t
Externí odkaz:
https://doaj.org/article/9ab68bc98ebe428ab7fbdafe21d2dd1c
Autor:
Koichi Hirata, Fumihiko Sakai, Takao Takeshima, Noboru Imai, Yasuhiko Matsumori, Ryuji Yoshida, Yotaro Numachi, Cheng Peng, Daniel D. Mikol, Sunfa Cheng
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background These subgroup analyses of a Phase 3, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of erenumab 70 mg in Japanese migraine patients with/without prior preventive treatment failure(s) (“fail
Externí odkaz:
https://doaj.org/article/7516175e8dab45fcbabc0355ccc7d7dd
Autor:
Noboru Imai
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 10092 (2023)
Migraine—a primary headache—has circadian and circannual rhythms in the onset of attacks. The circadian and circannual rhythms involve the hypothalamus, which is strongly associated with pain processing in migraines. Moreover, the role of melaton
Externí odkaz:
https://doaj.org/article/4673da27546344eca4421ff27a56ea23
Autor:
Keisuke Suzuki, Takao Takeshima, Hisaka Igarashi, Noboru Imai, Daisuke Danno, Toshimasa Yamamoto, Eiichiro Nagata, Yasuo Haruyama, Takashi Mitsufuji, Shiho Suzuki, Yasuo Ito, Mamoru Shibata, Hisanori Kowa, Shoji Kikui, Tomohiko Shiina, Madoka Okamura, Muneto Tatsumoto, Koichi Hirata
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Objectives To assess the impacts of social situation changes due to the coronavirus disease 2019 (COVID-19) pandemic on headache-related disability and other symptoms in patients with migraine in Japan. Methods We conducted a multicentre, cr
Externí odkaz:
https://doaj.org/article/9483e97dd9b44009a57e83cdd2ccd7f6